Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: CSL BEHRING CANADA INC
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Approved | 02459531 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 250 UNIT / VIAL |
| Approved | 02459558 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 500 UNIT / VIAL |
| Approved | 02459566 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 1000 UNIT / VIAL |
| Approved | 02459574 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 1500 UNIT / VIAL |
| Approved | 02459582 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 2000 UNIT / VIAL |
| Approved | 02459590 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 2500 UNIT / VIAL |
| Approved | 02459604 | CSL BEHRING CANADA INC | AFSTYLA | Human | Yes | Schedule D | 1 | LONOCTOCOG ALFA | 3000 UNIT / VIAL |
| Marketed | 02274663 | CSL BEHRING CANADA INC | ALBUREX - 25 | Human | Yes | Schedule D | 1 | ALBUMIN (HUMAN) | 25 % |
| Marketed | 02274655 | CSL BEHRING CANADA INC | ALBUREX - 5 | Human | Yes | Schedule D | 1 | ALBUMIN (HUMAN) | 5 % |
| Marketed | 02436078 | CSL BEHRING CANADA INC | BERINERT 1500 | Human | Yes | Schedule D | 1 | C1 ESTERASE INHIBITOR (HUMAN) | 1500 UNIT / VIAL |
| Marketed | 02352575 | CSL BEHRING CANADA INC | BERINERT 500 | Human | Yes | Schedule D | 1 | C1 ESTERASE INHIBITOR (HUMAN) | 500 UNIT / VIAL |
| Marketed | 02410826 | CSL BEHRING CANADA INC | BERIPLEX P/N 1000 | Human | Yes | Schedule D | 6 | COAGULATION FACTOR II (HUMAN) | 1600 UNIT |
| Marketed | 02359251 | CSL BEHRING CANADA INC | BERIPLEX P/N 500 | Human | Yes | Schedule D | 6 | COAGULATION FACTOR II (HUMAN) | 800 UNIT |
| Marketed | 02418746 | CSL BEHRING CANADA INC | CORIFACT 1250 | Human | Yes | Schedule D | 1 | FACTOR XIII | 1250 UNIT / VIAL |
| Marketed | 02418738 | CSL BEHRING CANADA INC | CORIFACT 250 | Human | Yes | Schedule D | 1 | FACTOR XIII | 250 UNIT / VIAL |
| Marketed | 02468069 | CSL BEHRING CANADA INC | HAEGARDA | Human | Yes | Schedule D | 1 | C1 ESTERASE INHIBITOR (HUMAN) | 2000 UNIT / VIAL |
| Marketed | 02468077 | CSL BEHRING CANADA INC | HAEGARDA | Human | Yes | Schedule D | 1 | C1 ESTERASE INHIBITOR (HUMAN) | 3000 UNIT / VIAL |
| Approved | 02542560 | CSL BEHRING CANADA INC | HEMGENIX | Human | Yes | Prescription | 1 | ETRANACOGENE DEZAPARVOVEC | 10000000000000 GENOME COPIES / ML |
| Approved | 02542560 | CSL BEHRING CANADA INC | HEMGENIX | Human | Yes | Schedule D | 1 | ETRANACOGENE DEZAPARVOVEC | 10000000000000 GENOME COPIES / ML |
| Marketed | 02370352 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
| Marketed | 02463059 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
| Marketed | 02463067 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
| Marketed | 02498251 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
| Marketed | 02535424 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
| Marketed | 02261219 | CSL BEHRING CANADA INC | HUMATE-P | Human | Yes | Schedule D | 2 | ANTIHEMOPHILIC FACTOR (HUMAN) | 300 UNIT / 5 ML |
| Marketed | 02261227 | CSL BEHRING CANADA INC | HUMATE-P | Human | Yes | Schedule D | 2 | ANTIHEMOPHILIC FACTOR (HUMAN) | 600 UNIT / 10 ML |
| Marketed | 02261235 | CSL BEHRING CANADA INC | HUMATE-P | Human | Yes | Schedule D | 2 | ANTIHEMOPHILIC FACTOR (HUMAN) | 1200 UNIT / 15 ML |
| Approved | 02451336 | CSL BEHRING CANADA INC | IDELVION | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 250 UNIT / VIAL |
| Approved | 02451344 | CSL BEHRING CANADA INC | IDELVION | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 500 UNIT / VIAL |
| Dormant | 02451352 | CSL BEHRING CANADA INC | IDELVION | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 1000 UNIT / VIAL |
| Approved | 02451360 | CSL BEHRING CANADA INC | IDELVION | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 2000 UNIT / VIAL |
| Approved | 02489627 | CSL BEHRING CANADA INC | IDELVION | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 3500 UNIT / VIAL |
| Marketed | 02304619 | CSL BEHRING CANADA INC | PRIVIGEN | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 10 % |
| Marketed | 02393352 | CSL BEHRING CANADA INC | RIASTAP | Human | Yes | Schedule D | 1 | FIBRINOGEN (HUMAN) | 1000 MG / VIAL |
| Cancelled Post Market | 02287994 | CSL BEHRING CANADA INC | SANDOGLOBULIN NF LIQUID | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 120 G / L |
| Cancelled Post Market | 02018993 | CSL BEHRING CANADA INC | STREPTASE | Human | Yes | Schedule D | 1 | STREPTOKINASE | 250000 UNIT / VIAL |
| Cancelled Post Market | 02019000 | CSL BEHRING CANADA INC | STREPTASE | Human | Yes | Schedule D | 1 | STREPTOKINASE | 750000 UNIT / VIAL |
| Cancelled Post Market | 02019019 | CSL BEHRING CANADA INC | STREPTASE | Human | Yes | Schedule D | 1 | STREPTOKINASE | 1500000 UNIT / VIAL |
| Cancelled Post Market | 02282518 | CSL BEHRING CANADA INC | VIVAGLOBIN | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN G (HUMAN) | 160 MG / ML |
| Approved | 02457911 | CSL BEHRING CANADA INC | ZEMAIRA | Human | Yes | Schedule D | 1 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 1000 MG / VIAL |
| Approved | 02494760 | CSL BEHRING CANADA INC | ZEMAIRA | Human | Yes | Schedule D | 1 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 4000 MG / VIAL |
| Approved | 02494779 | CSL BEHRING CANADA INC | ZEMAIRA | Human | Yes | Schedule D | 1 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 5000 MG / VIAL |
Application information
Related information
Contact us
Version 4.0.2